Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
4 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
MiR126-targeted-nanoparticles combined with PI3K/AKT inhibitor as a new strategy to overcome melanoma resistance.
Mol Ther. 2024 Jan 3;32(1):152-167. doi: 10.1016/j.ymthe.2023.11.021. Epub 2023 Nov 21.
Mol Ther. 2024.
PMID: 37990493
Free article.
BRAF Mutations in Melanoma: Biological Aspects, Therapeutic Implications, and Circulating Biomarkers.
Castellani G, Buccarelli M, Arasi MB, Rossi S, Pisanu ME, Bellenghi M, Lintas C, Tabolacci C.
Castellani G, et al. Among authors: arasi mb.
Cancers (Basel). 2023 Aug 8;15(16):4026. doi: 10.3390/cancers15164026.
Cancers (Basel). 2023.
PMID: 37627054
Free PMC article.
Review.
Item in Clipboard
Advances in Natural or Synthetic Nanoparticles for Metastatic Melanoma Therapy and Diagnosis.
Arasi MB, Pedini F, Valentini S, Felli N, Felicetti F.
Arasi MB, et al.
Cancers (Basel). 2020 Oct 9;12(10):2893. doi: 10.3390/cancers12102893.
Cancers (Basel). 2020.
PMID: 33050185
Free PMC article.
Review.
Item in Clipboard
Joint action of miR-126 and MAPK/PI3K inhibitors against metastatic melanoma.
Pedini F, De Luca G, Felicetti F, Puglisi R, Boe A, Arasi MB, Fratini F, Mattia G, Spada M, Caporali S, Biffoni M, Giuliani A, Carè A, Felli N.
Pedini F, et al. Among authors: arasi mb.
Mol Oncol. 2019 Sep;13(9):1836-1854. doi: 10.1002/1878-0261.12506. Epub 2019 Aug 6.
Mol Oncol. 2019.
PMID: 31115969
Free PMC article.
Item in Clipboard
Cite
Cite